Financhill
Buy
69

AKRO Quote, Financials, Valuation and Earnings

Last price:
$49.43
Seasonality move :
-13.61%
Day range:
$48.90 - $51.13
52-week range:
$17.86 - $58.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.72x
Volume:
1.4M
Avg. volume:
1.7M
1-year change:
152.78%
Market cap:
$3.5B
Revenue:
--
EPS (TTM):
-$3.78

Earnings Data

Next earnings date for AKRO
Feb 28
2025
Most recent earnings per share
-$1.05
Missed by $0.12
(Nov 8/2024)
Consensus Estimate
-$0.93
(Nov 8/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

AKRO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 -- -- -- -$1.11 --
02/28/2025 Q4 -- -- -- -$1.12 --
11/08/2024 Q3 -- -- -$1.05 -$0.93 -$0.12
08/09/2024 Q2 -- -- -$0.81 -$0.89 $0.08
05/10/2024 Q1 -- -- -$0.90 -$0.93 $0.03
02/29/2024 Q4 -- -- -$1.02 -$0.83 -$0.19
11/13/2023 Q3 -- -- -$0.71 -$0.69 -$0.02
08/11/2023 Q2 -- -- -$0.60 -$0.71 $0.11
05/15/2023 Q1 -- -- -$0.55 -$0.64 $0.09
03/17/2023 Q4 -- -- -$0.49 -$0.83 $0.34
11/04/2022 Q3 -- -- -$0.92 -$0.73 -$0.19
08/05/2022 Q2 -- -- -$0.77 -$0.86 $0.09
05/06/2022 Q1 -- -- -$0.74 -$0.84 $0.10
02/25/2022 Q4 -- -- -$0.93 -$0.81 -$0.12
11/12/2021 Q3 -- -- -$0.70 -$0.91 $0.21
08/13/2021 Q2 -- -- -$0.83 -$0.71 -$0.12
05/13/2021 Q1 -- -- -$0.43 -$0.94 $0.51
03/16/2021 Q4 -- -- -$0.86 -$0.60 -$0.26
11/12/2020 Q3 -- -- -$0.63 -$0.67 $0.04
08/12/2020 Q2 -- -- -$0.57 -$0.62 $0.05
05/13/2020 Q1 -- -- -$0.42 -$0.61 $0.19
03/16/2020 Q4 -- -- -$0.55 -$0.58 $0.03
11/12/2019 Q3 -- -- -$0.56 -$0.43 -$0.13
08/12/2019 Q2 -- -- -$0.26 -$0.36 $0.10

Akero Therapeutics Earnings Questions

  • How Much did Akero Therapeutics Generate in Revenue Last Quarter?

    Akero Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Akero Therapeutics Beat Earnings Last Quarter?

    Akero Therapeutics announced earnings per share of -$1.05 which represents a miss of analyst forecast a -$0.93 per share.

  • Is Akero Therapeutics Profitable?

    Akero Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Akero Therapeutics EPS Next Year?

    Akero Therapeutics's earnings are forecast to decrease from -$2.89 per share to -$3.95 per share next year representing a decrease of -37.38%.

  • When is Akero Therapeutics's Earnings Date?

    Akero Therapeutics's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Will Palantir Stock Be Worth in 2030?
What Will Palantir Stock Be Worth in 2030?

Palantir Technologies (NYSE: PLTR) has emerged from a growth slowdown…

Is Rollins Stock a Buy, Sell or Hold?
Is Rollins Stock a Buy, Sell or Hold?

Pest control giant Rollins (NYSE:ROL) is the parent company of…

Why Did Bill Ackman Buy Uber?
Why Did Bill Ackman Buy Uber?

In early 2025, billionaire investor Bill Ackman, CEO of Pershing…

Stock Ideas

Buy
59
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 111x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
65
ATEX alert for Feb 12

Anterix [ATEX] is down 0.72% over the past day.

Buy
87
GDS alert for Feb 12

GDS Holdings [GDS] is up 0.32% over the past day.

Sell
30
SPSC alert for Feb 12

SPS Commerce [SPSC] is up 0.17% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock